Male Breast Cancer Completed Phase 2 Trials for Sargramostim (DB00020)

Back to Male Breast Cancer

Also known as: Breast Cancer, Male / Breast Cancer - Male / Breast cancer male / Cancer of male breast / Malignant neoplasm of male breast (disorder) / Carcinoma of male breast (disorder) / Breast cancer male NOS

IndicationStatusPhase
DBCOND0028546 (Male Breast Cancer)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00343109
Vaccine Therapy in Treating Patients Receiving Trastuzumab For HER2-Positive Stage IIIB-IV Breast CancerPrevention
NCT00003199
Combination Chemotherapy and Peripheral Blood Stem Cell Transplant Followed By Aldesleukin and Sargramostim in Treating Patients With Inflammatory Stage IIIB or Metastatic Stage IV Breast CancerTreatment